Dr. Mark H. Einstein is Professor and Chair at the Department of Obstetrics, Gynecology, & Reproductive Health and Associate Dean of Clinical Research at Rutgers New Jersey Medical School. He currently serves as President of the ASCCP, the society for lower genital tract disorders.
Dr. Einstein is an internationally-renowned expert in gynecologic oncology, particularly for his clinical and research focus in cervical cancer and human papillomavirus (HPV). He has led numerous multi-institutional clinical trials in targeting HPV and cervical cancer as well as cervical cancer prevention. He has been active in translating clinical trial and translational data into clinical practices regarding cervical cancer prevention including as 1) a member of the Steering Committee for the ASCCP Cervical Screening and Management Guidelines, 2) a workgroup member of the American Cancer Society and the Society of Gynecologic Oncologists separate recommendations for HPV vaccines, 3) a consultant to the World Health Organization (WHO), developing their modules on the immunologic basis of HPV vaccines, and harmonizing with current cervical cancer screening, and 4) principal investigator for many U.S. and global therapeutic HPV-targeted therapy trials.